Verona Pharma Debt 2024

Verona Pharma Aktienanalyse

What does Verona Pharma do?

Verona Pharma PLC is a British biopharmaceutical company that focuses on the development of innovative drugs for the treatment of respiratory diseases. The company was founded in 2005 and is headquartered in London. Verona Pharma's business model is based on the research and development of drugs for the treatment of respiratory diseases, particularly for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Verona Pharma utilizes a platform technology called PDE4 inhibition, which allows for the reduction of inflammation in the airways and thus alleviates the symptoms of respiratory diseases. Verona Pharma has several divisions in which the company is active. One of the divisions is the research and development of new drugs. Verona Pharma has its own product pipeline focused on the development of new PDE4 inhibitors. Verona Pharma's PDE4 inhibitors are being developed as inhalable drugs and are intended to provide rapid relief of respiratory disease symptoms. Another aspect of Verona Pharma's business is the distribution of already approved drugs. Verona Pharma works closely with partners who handle the marketing and sales of the drugs. One of Verona Pharma's already approved products is RPL554, a PDE3/PDE4 inhibitor developed for the treatment of COPD and asthma. Verona Pharma has experienced strong expansion in recent years and is now operating internationally. The company has subsidiaries in the UK, the US, and Belgium, and employs more than 100 people. Verona Pharma collaborates closely with leading research institutes and universities to advance innovations in the field of respiratory diseases. Overall, Verona Pharma offers a wide portfolio of products and services in the field of respiratory diseases. The company aims to improve the quality of life for patients with respiratory diseases and develop innovative therapies that provide rapid and effective relief of symptoms. With its strong research and development activities and international network, Verona Pharma is able to develop and market innovative drugs that offer true value to patients with respiratory diseases. Verona Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Verona Pharma's Debt Structure

Verona Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Verona Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Verona Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Verona Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Verona Pharma stock

What is the debt of Verona Pharma this year?

Verona Pharma has a debt level of -223.4 USD this year.

What was the debt of Verona Pharma compared to the previous year?

The debt of Verona Pharma has increased by 2.48% compared to the previous year increased.

What are the consequences of high debt for investors in Verona Pharma?

High debt can pose a risk for investors of Verona Pharma, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Verona Pharma?

Low debt means that Verona Pharma has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Verona Pharma affect the company?

An increase in debt of Verona Pharma can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Verona Pharma affect the company?

A reduction in debt of Verona Pharma can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Verona Pharma?

Some factors that can influence the debt of Verona Pharma include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Verona Pharma so important for investors?

The debts of Verona Pharma are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Verona Pharma take to change the debt?

To change the debt, Verona Pharma can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Verona Pharma pay?

Over the past 12 months, Verona Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Verona Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Verona Pharma?

The current dividend yield of Verona Pharma is .

When does Verona Pharma pay dividends?

Verona Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Verona Pharma?

Verona Pharma paid dividends every year for the past 0 years.

What is the dividend of Verona Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Verona Pharma located?

Verona Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Verona Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Verona Pharma from 9/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/16/2024.

When did Verona Pharma pay the last dividend?

The last dividend was paid out on 9/16/2024.

What was the dividend of Verona Pharma in the year 2023?

In the year 2023, Verona Pharma distributed 0 USD as dividends.

In which currency does Verona Pharma pay out the dividend?

The dividends of Verona Pharma are distributed in USD.